The PE Ratio as of December 2024 (TTM) for Compugen Ltd. (CGEN) is 53.33

According to Compugen Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 53.33. This represents a change of 1.98% compared to the average of 2.56 of the last 4 quarters.

Compugen Ltd. (CGEN) Historical PE Ratio (quarterly & annually)

How has CGEN PE Ratio performed in the past?

The mean historical PE Ratio of Compugen Ltd. over the last ten years is -14.06. The current 53.33 PE Ratio has changed -38035.61% with respect to the historical average. Over the past ten years (40 quarters), CGEN's PE Ratio was at its highest in in the March 2018 quarter at 529.03. The PE Ratio was at its lowest in in the December 2015 quarter at -171.01.

Compugen Ltd. (CGEN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Compugen Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Compugen Ltd. (CGEN) Average PE Ratio

How has CGEN PE Ratio performed in the past?

The current PE Ratio of Compugen Ltd. (CGEN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Compugen Ltd. (CGEN) PE Ratio vs. Peers

How is CGEN’s PE Ratio compared to its peers?

Compugen Ltd.’s PE Ratio is greater than BiomX Inc. (-317.92), greater than Pluri Inc. (-1.06), greater than Surface Oncology, Inc. (-0.91), greater than BioLineRx Ltd. (-1.04), greater than iTeos Therapeutics, Inc. (-2.66), greater than Icosavax, Inc. (-15.78), greater than Mirati Therapeutics, Inc. (-11.26), greater than VectivBio Holding AG (-7.94), greater than Annexon, Inc. (-6.23), greater than Allogene Therapeutics, Inc. (-1.54), greater than Beam Therapeutics Inc. (-16.53), greater than Sana Biotechnology, Inc. (-1.35), greater than Caribou Biosciences, Inc. (-1.03), greater than Editas Medicine, Inc. (-0.47), less than Can-Fite BioPharma Ltd. (0), greater than ImmuCell Corporation (-1.53), greater than Evogene Ltd. (-0.05), greater than CollPlant Biotechnologies Ltd. (-3.17), greater than null (-2.30),

Build a custom stock screener for Compugen Ltd. (CGEN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Compugen Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Compugen Ltd. (CGEN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Compugen Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.